For Sensitive & Regulated Research

Refine sensitive study materials before recruitment.

Find unclear language and missing context early, then take the revised design through the human, clinical, privacy, and legal review it requires.

Request Early Access

Improve the instrument without using identifiable records

Questions about health, financial strain, workplace risk, or stigmatized experiences deserve careful human research. Early drafts can still be rehearsed with synthetic participants so obvious wording problems are fixed before recruitment.

Use fictional, public, de-identified, or otherwise authorized project materials. Do not upload identifiable records simply because the participants are synthetic. Your organization’s privacy, security, legal, and research requirements still apply to the documents stored in a project.

Example: patient letter review

A care team adds a proposed navigation letter, a fictional care pathway, and the current FAQ. It asks supported audience groups to explain what action the letter requests and which terms require more context.

The team inspects the room’s source requests and transcript. It revises the letter, then takes those revisions to patient advisors and the required review bodies. AnthroSim provides questions for that work; it does not establish comprehension, safety, consent, or clinical effectiveness.

A bounded exploratory tool

The platform supports an orchestrated discussion, bounded project-source lookup, inspectable source-use records, final ballots, and JSON export. It does not replace an IRB, ethics review, clinical trial, patient advisory board, or direct engagement with an affected community.

Review the evidence boundary →

Request Early Access

We're onboarding a first cohort: academic and applied researchers, market research firms, enterprise product teams, law firms, policy organizations, and teams planning sensitive or regulated studies.

Early access participants receive preferred rates and priority onboarding.

No commitment. Pricing finalized at launch.